NYC Twins Turn $500K Telehealth Failure into $2 B Platform

Zachary and Elias Dorf, New York-born entrepreneurs, initially invested close to $500,000 and a year’s work into a telehealth platform for the prescription eyelash drug Latisse, which did not meet expectations. The technology they built—prescription handling, consultations, payments and pharmacy integration—proved valuable to other founders, leading the twins to shift from consulting to creating a reusable platform named Bask Health.

Described as the "Shopify for telehealth," the service provides a marketplace of over 60 pharmacies and 10 doctor groups, along with customizable templates for rapid launch. As demand for remote prescribing, especially for GLP-1 weight-loss medications, surged, Bask Health’s transaction volume grew to more than $1 billion in March 2026 and has since reached $2 billion, serving over 10 million patients. The firm has expanded its staff from about 10 to roughly 150 employees and plans to enter the UK market later this year, navigating new regulatory landscapes. The brothers continue to run the business from their SoHo office, with Zachary overseeing engineering and partnerships and Elias handling sales and customer success.